DR info

Clinical trials : 40 / Drugs : 47 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 141

IgG4-related disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
300	IgG4-related disease
13	Multiple sclerosis/Neuromyelitis optica
46	Malignant rheumatoid arthritis
49	Systemic lupus erythematosus
11	Myasthenia gravis
51	Scleroderma
222	Primary nephrotic syndrome
53	Sjogren syndrome
65	Primary immunodeficiency
96	Crohn disease
35	Pemphigus
271	Ankylosing spondylitis
60	Aplastic anemia
107	Juvenile idiopathic arthritis
44	Wegener granulomatosis
284	Diamond-Blackfan anemia
61	Autoimmune hemolytic anemia
285	Fanconi anemia
43	Microscopic polyangiitis
28	Systemic amyloidosis
19	Lysosomal storage disease
84	Sarcoidosis
95	Autoimmune hepatitis
97	Ulcerative colitis
2	Amyotrophic lateral sclerosis
162	Pemphigoid
164	Oculocutaneous albinism
66	IgA nephropathy
93	Primary biliary cholangitis
226	Interstitial cystitis with Hunners ulcer
86	Pulmonary arterial hypertension
45	Eosinophilic granulomatosis with Polyangiitis
94	Primary sclerosing cholangitis
6	Parkinson disease
251	Urea cycle disorder
42	Polyarteritis nodosa
41	Giant cell arteritis
55	Relapsing polychondritis
50	Dermatomyositis
337	Homocystinuria
224	Purpura nephritis
85	Idiopathic interstitial pneumonia
283	Acquired pure red cell aplasia
256	Muscle glycogenosis
331	Idiopathic multicentric castleman disease
228	Bronchiolitis obliterans
98	Eosinophilic gastrointestinal disease
296	Biliary atresia
298	Hereditary pancreatitis
70	Spinal stenosis
14	Chronic inflammatory demyelinating polyneuropathy
52	Mixed connective tissue disease
220	Rapidly progressive glomerulonephritis
30	Distal myopathy
160	Congenital ichthyosis